Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Electronic Health Records Poised to Benefit Healthcare with New Partnerships

Electronic Health Records (EHR) Big Tech is teaming up with big tech to transform healthcare. Three giants in the electronic health record industry, Epic, Meditech, and Oracle Cerner, recently announced agreements with several Big Tech organizations and some tech startups to provide improved offerings to healthcare organizations. Epic entered into an agreement with Google Cloud,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Electronic Health Records (EHR) Big Tech is teaming up with big tech to transform healthcare.

Three giants in the electronic health record industry, Epic, Meditech, and Oracle Cerner, recently announced agreements with several Big Tech organizations and some tech startups to provide improved offerings to healthcare organizations.

Epic entered into an agreement with Google Cloud, enabling health systems to migrate their EHRs to the cloud. Meditech entered a similar partnership with Google. In addition, Meditech is integrating its platform with digital care company SeamlessMD.

Oracle Cerner partnered with life sciences company Labcorp to manage hospital-based laboratories in 10 states. This partnership allows Labcorp to standardize and optimize workflows for better efficiency and support information sharing.

If overcoming healthcare challenges, and improving the EHR process is the goal, then these announcements are sure to move the industry in a positive direction. David Kemp, Healthcare Lead at MarketScale, shares the industry’s enthusiasm about the partnerships.

David’s Thoughts

“So if you’ve been around healthcare long enough, you know interoperability is a big challenge. Exchanging data between systems is important for a lot of reasons, mainly to integrate that data to make better, smarter decisions for the patient to improve the patient outcome. But interoperability has always been a challenge, and so exciting news here is that Epic, arguably the largest electronic health record provider in the space is launching The Connection Hub on January 9th. It’s essentially a website where other vendors can prove and be documented or attain interoperability certification through Epic. This will allow providers, and other Epic users to come on and see what vendors they should use to maybe fill in some gaps or some holes in their functionality.

So I think this is a good step for the industry. I think it’s a good step for providers to be able to have access to that information and make smarter, easier, quicker decisions on what vendors to consider when evaluating during the sales process. But it’ll be interesting to see what Epic does with this data.

Now they get to see who has that integration built out in the space, what maybe features or functionalities they’re able to provide to the provider community, and maybe they start making decisions on what next features and functionalities they want to add to the Epic system. Ultimately, I think it’s a benefit for everybody.

It allows those vendors to get exposure to the providers that they want to work with. It gives the information to the providers when looking to fill gaps in their features and functionality, but Epic because they own the data might benefit the most. Overall, I think it’s a positive step in the right direction and uh, we’ll see what it really looks like on January 9th when Epic launches the Connection Hub.”

Article by James Kent

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512